期刊文献+

莱菔素通过阻断STAT3信号通路杀伤三阴性乳腺癌细胞MDA-MB-468和MDA-MA-231 被引量:6

Sulforaphene kills triple negative breast cancer MDA-MB-468 and MDA-MA-231 cells by blocking STAT3 signaling pathway
原文传递
导出
摘要 目的:探讨染色体区域维持因子1(CRM1)抑制剂莱菔素(LFS-01)通过抑制信号转导及转录激活因子3(STAT3)信号通路杀伤三阴性乳腺癌(TNBC)细胞的作用及其机制。方法:通过分子动力学模拟技术,验证LFS-01是否可与CRM1分子结构上的核输出信号(NES)口袋结合。通过CCK-8法检测LFS-01对4种不同的乳腺癌细胞杀伤活力。用不同浓度的LFS-01处理TNBC细胞MDA-MB-468和MDA-MB-231,免疫荧光法检测CRM1货物蛋白STAT3以及带有NES序列的蛋白在细胞内定位的变化;WB检测LFS-01对STAT-3信号通路以及其下游蛋白表达的影响;WB、细胞免疫荧光和透射电镜法检测自噬的发生;通过流式细胞术检测药物对细胞周期和凋亡的影响。结果:分子动力学模拟结果表明,LFS-01能够与CRM1的NES口袋结合,显示其在结构上影响后者蛋白转运功能的可能性。LFS-01能特异性杀伤TNBC细胞MDA-MB-468和MDA-MB-231。10μmol/L LFS-01处理后TNBC细胞中STAT3和带有NES标签的蛋白均被阻滞于细胞核中,而在对照组中这些蛋白均匀分布在细胞质中。随着LFS-01剂量的提高和处理时间的延长,MDA-MB-468和MDA-MB-231细胞中磷酸化STAT3蛋白、Bcl-xL和Cylin D1表达均降低,细胞内自噬标志蛋白LC3B表达上升;同时出现高密度、多层的团状自噬小体;细胞周期阻滞于S期,并且凋亡率显著升高(P<0.05或P<0.01)。结论:LFS-01可阻断CRM1运载蛋白出核、进而抑制STAT3信号通路的激活,从而促进TNBC细胞MDA-MB-468和MDA-MB-231发生自噬、细胞周期阻滞和凋亡。 Objective :To investigate the role and mechanism of chromosomal region maintenance 1(CRM1) inhibitor sulforaphene(LFS-01) in killing triple negative breast cancer(TNBC) cells by inhibiting signal transducer and activator of transcription 3(STAT3) signaling pathways. Methods: Whether LFS-01 could combine with the NES pocket of CRM1 was verified by molecular dynamics simulation techniques. The killing activity of LFS-01 on four different breast cancer cell lines was detected by CCK-8 method. TNBC MDA-MB-468 and MDA-MB-231 cells were treated with different concentrations of LFS-01, and the intracellular localization of CRM1 cargo protein STAT3 and protein with NES sequence was detected by immunofluorescence;WB was used to detect the effect of LFS-01 on the expression of STAT-3 signaling pathway and its downstream proteins;WB, cellular immunofluorescence and transmission electron microscopy were adopted to detect the occurrence of autophagy;the effect of LFS-01 on cell cycle and apoptosis was detected by flow cytometry. Results: Molecular dynamics simulations showed that LFS-01 can bind to the NES pocket of CRM1, indicating that it may structurally affect the latter’s protein transport function. LFS-01 could specifically kill TNBC MDA-MB-468 and MDA-MB-231 cells. STAT3 and NES-tagged proteins were mainly blocked in the nucleus of TNBC cells after the treatment with 10 μ mol/L LFS-01, while they were evenly distributed in the cytoplasm in the control group. The expressions of phosphorylated STAT3 protein, Bcl-xL and Cylin D1 were decreased in MDA-MB-468 and MDA-MB-231 cells with the increase of LFS-01 dose and the prolongation of treatment time;the expression of autophagy marker protein LC3 B increased, and highdensity, multi-layered autophagosomes appeared at the same time;cell cycle arrest was observed in S phase and apoptosis rate was significantly increased(P<0.05 or P<0.01). Conclusion: LFS-01 blocks the export of CRM1 carrier protein, thereby inhibiting the activation of STAT3 signaling pathway and promoting autophagy, cell cycle arrest and apoptosis in TNBC MDA-MB-468 and MDAMB-231 cells.
作者 高久蕉 张琦 杨永亮 GAO Jiujiao;ZHANG Qi;YANG Yongliang(Center for Molecular Medicine,School of Bioengineering,Dalian University of Technology,Dalian 116023,Liaoning,China)
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2019年第8期837-844,共8页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81874301)~~
关键词 莱菔素 信号转导及转录激活因子3 染色体区域维持因子1 三阴性乳腺癌 MDA-MB-468细胞 MDA-MB-231细胞 sulforaphene(LFS-01) signal transducer and activator of transcription 3(STAT3) chromosomal region maintenance 1(CRM1) triple-negative breast cancer(TNBC) MDA-MB-468 cell MDA-MB-231 cell
  • 相关文献

参考文献2

二级参考文献43

  • 1Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[ J]. Nature ,2000,406 : 747 - 752.
  • 2Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochenical and clinical characterization of the basal-like subtype of invasive breast carcinoma [ J ]. Clin Cancer Res, 2004,10 ( 16 ) :5367 - 5374.
  • 3Bertucci F. How basal are triple-negative breast cancers? [ J]. Int J Cancer,2008,123 ( 1 ) : 936 - 240.
  • 4Sasa M, Bando Y,Takahashi M, et al. Screening for basal marker expression is necessary for decision of therapeutic strategy tbr triple-negative breast cancer [ J ]. J Surg Oncol, 2008,97 ( 1 ) : 30-34.
  • 5Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options [ J ]. Lancet Oncol,2007,8 : 235 - 244.
  • 6Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCAI mutations and a basal epithelial phenotype in breast cancer[J]. J Natl Cancer Inst,2003,95 : 1482 - 1485.
  • 7Korsehing E, Packeisen J, Agelopoulos K,et al. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenelic pathways of breast carcinogenesis[ J ]. Lab Invest,2002,82 : 1525 - 1533.
  • 8Foulkes WD, Brunet JS, Stefansson IM,et al. The prognostic implication of the basal-like (cyclin E^high/p27^low/p53^+/ glomeruloid-microvascular-proliferation^+ ) phenotype of BRCA1-related breast cancer[ J]. Cancer Res,2004, 64 : 830 - 835.
  • 9Bergamaschi A, Kim YH,Wang P,et al. Distinct patterns of DNA copy number alteration are associated with different clinieopathological features and gene-expression subtypes of breast cancer [ J]. Genes Chromosomes Cancer, 2006,45 : 1033 - 1040.
  • 10Turner N, Tutt A, Ashworth A. Hallmarks of BRCkness' in sporadic caneers[J]. Nat Rev Cancer,2004-,4:814 -819.

共引文献897

同被引文献149

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部